MktsMarkets

Nektar Therapeutics
NASDAQ: NKTRKey statistics
NKTR News
Stories mentioning NKTR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 10,861 | 21,807 | 11,790 | 11,175 | 10,460 | 29,175 | 24,124 | 23,489 |
| Cost of Goods Sold | 0.00 | 0.00 | 0.00 | 0.00 | 7,977 | 4,435 | 9,740 | |
| Gross Profit | 21,807 | 11,790 | 11,175 | 10,460 | 21,198 | 19,689 | 13,749 | |
| Operating Expenses | ||||||||
| Research & Development | 35,680 | 29,712 | 27,252 | 29,886 | 30,480 | 28,745 | 35,031 | 29,724 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (39,054) | (27,665) | (31,672) | (36,230) | (44,535) | 14,348 | (34,345) | (49,774) |
| Interest Income | 4,242 | 2,776 | 2,819 | 1,969 | 2,874 | 2,942 | 3,437 | 3,901 |
| Interest Expense | ||||||||
| Other Expense | (336.00) | (44.00) | (121.00) | 260.00 | 266.00 | (135.00) | (120.00) | (36.00) |
| Pretax Income | 7,002 | (37,048) | (52,317) | |||||
| Tax Provision | 64.00 | 31.00 | (33.00) | (188.00) | 52.00 | (259.00) | 9.00 | 46.00 |
| Net Income (Loss) | (44,904) | (36,079) | (35,522) | (41,593) | (50,882) | 7,261 | (37,057) | (52,363) |
| Earnings Per Share (Basic) | (1.82) | (2.14) | (1.87) | (2.95) | (3.62) | 0.53 | (2.66) | (3.76) |
| Earnings Per Share (Diluted) | (1.82) | (2.14) | (1.87) | (2.95) | (3.62) | 0.53 | (2.66) | (3.76) |
| Weighted Average Shares Outstanding (Basic) | 24,736 | 16,871 | 18,947 | 14,087 | 14,063 | 13,711 | 13,950 | 13,921 |
| Weighted Average Shares Outstanding (Diluted) | 24,736 | 16,871 | 18,947 | 14,087 | 14,063 | 13,711 | 13,950 | 13,921 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About NKTR
Nektar Therapeutics (NASDAQ: NKTR) is a stock listed on the Nasdaq Stock Market under the ticker symbol NKTR. It last traded at $37.83 (Nov 9, 2026, 4:00 PM ET), up 1.5% on the day. That gives Nektar Therapeutics a market capitalisation of $1.3B.
Over the past 52 weeks NKTR has traded between $33.40 and $109.00.
Revenue for the quarter ended Mar 31, 2026 was $10.9M; a net loss of $44.9M. Revenue was up 3.8% from $10.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $10.9M | -$44.9M | -413.4% |
| Dec 31, 2025 | $21.8M | -$36.1M | -165.4% |
| Sep 30, 2025 | $11.8M | -$35.5M | -301.3% |
| Jun 30, 2025 | $11.2M | -$41.6M | -372.2% |
From Nektar Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…